Patents by Inventor Sridhar Narayan

Sridhar Narayan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Post-top light fixture
    Patent number: 11953179
    Abstract: A light fixture (100) includes a carriage (104), a hood (102) rotatably attached to the carriage (104), and a light engine (150, 900, 1108) that includes a plate (110, 902) and a light module (112, 926). The light module (112, 926) is attached to the plate (110, 902), and the plate (110, 902) is rotatably attached to the carriage (104).
    Type: Grant
    Filed: October 19, 2021
    Date of Patent: April 9, 2024
    Assignee: SIGNIFY HOLDING, B.V.
    Inventors: Kunal Shivapurkar, Rajesh Narayan Kalbhor, Sridhar Reddy Nimma
  • MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF
    Publication number: 20220340604
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: March 25, 2022
    Publication date: October 27, 2022
    Inventors: Kristina Michelle FETALVERO, Sridhar Narayan, David John O'Neill, Eddine Saiah, Shomit Sengupta
  • Heteroaryl Rheb inhibitors and uses thereof
    Patent number: 11339144
    Abstract: The present invention provides compounds of general Formula I and I?: compositions thereof, and methods of using same to treat Rheb-mediated disorders.
    Type: Grant
    Filed: April 9, 2018
    Date of Patent: May 24, 2022
    Assignee: NAVITOR PHARMACEUTICALS, INC.
    Inventors: Sarah Mahoney, Lisa Molz, Sridhar Narayan, Eddine Saiah
  • Modulators of Sestrin-GATOR2 interaction and uses thereof
    Patent number: 11325924
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: July 29, 2020
    Date of Patent: May 10, 2022
    Assignee: NAVITOR PHARMACEUTICALS, INC.
    Inventors: Kristina Michelle Fetalvero, Sridhar Narayan, David John O'Neill, Eddine Saiah, Shomit Sengupta
  • Tetrahydropyrazolopyrimidine compounds
    Patent number: 11130758
    Abstract: Embodiments of the disclosure relate to tetrahydropyrazolopyrimidine compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.
    Type: Grant
    Filed: April 10, 2020
    Date of Patent: September 28, 2021
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Roch Boivin, Eric Carlson, Atsushi Endo, Hans Hansen, Lynn D. Hawkins, Sally Ishizaka, Matthew Mackey, Sridhar Narayan, Takashi Satoh, Shawn Schiller
  • HETEROARYL RHEB INHIBITORS AND USES THEREOF
    Publication number: 20210238165
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same. Compositions comprising a compound of this invention or a pharmaceutically acceptable derivative thereof and a pharmaceutically acceptable carrier, adjuvant, or vehicle. The amount of the compound in compositions of this invention is such that it is effective to measurably inhibit Rheb, in a biological sample or in a patient.
    Type: Application
    Filed: April 9, 2018
    Publication date: August 5, 2021
    Inventors: Sarah MAHONEY, Lisa MOLZ, Sridhar NARAYAN, Eddine SAIAH
  • MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF
    Publication number: 20210047347
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: July 29, 2020
    Publication date: February 18, 2021
    Inventors: Kristina Michelle FETALVERO, Sridhar NARAYAN, David John O'NEILL, Eddine SAIAH, Shomit SENGUPTA
  • TETRAHYDROPYRAZOLOPYRIMIDINE COMPOUNDS
    Publication number: 20200347050
    Abstract: Embodiments of the disclosure relate to tetrahydropyrazolopyrimidine compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.
    Type: Application
    Filed: April 10, 2020
    Publication date: November 5, 2020
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Roch BOIVIN, Eric CARLSON, Atsushi ENDO, Hans HANSEN, Lynn D. HAWKINS, Sally ISHIZAKA, Matthew MACKEY, Sridhar NARAYAN, Takashi SATOH, Shawn SCHILLER
  • Modulators of Sestrin-GATOR2 interaction and uses thereof
    Patent number: 10752644
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: July 18, 2019
    Date of Patent: August 25, 2020
    Assignee: NAVITOR PHARMACEUTICALS, INC.
    Inventors: Kristina Michelle Fetalvero, Sridhar Narayan, David John O'Neill, Eddine Saiah, Shomit Sengupta
  • Tetrahydropyrazolopyrimidine compounds
    Patent number: 10640500
    Abstract: Embodiments of the disclosure relate to tetrahydropyrazolopyrimidine compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: May 5, 2020
    Assignee: EISAI R&D MANAGEMENT CO., LTD.
    Inventors: Roch Boivin, Eric Carlson, Atsushi Endo, Hans Hansen, Lynn D. Hawkins, Sally Ishizaka, Matthew Mackey, Sridhar Narayan, Takashi Satoh, Shawn Schiller
  • MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF
    Publication number: 20200079800
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: July 18, 2019
    Publication date: March 12, 2020
    Inventors: Kristina Michelle Fetalvero, Sridhar Narayan, David John O'Neill, Eddine Saiah, Shomit Sengupta
  • Modulators of sestrin-GATOR2 interaction and uses thereof
    Patent number: 10414782
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: May 9, 2018
    Date of Patent: September 17, 2019
    Assignee: Navitor Pharmaceuticals, Inc.
    Inventors: Kristina Michelle Fetalvero, Sridhar Narayan, David John O'Neill, Eddine Saiah, Shomit Sengupta
  • MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF
    Publication number: 20190048029
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: May 9, 2018
    Publication date: February 14, 2019
    Inventors: Kristina Michelle Fetalvero, Sridhar Narayan, David John O'Neill, Eddine Saiah, Shomit Sengupta
  • Modulators of sestrin-GATOR2 interaction and uses thereof
    Patent number: 10100066
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: October 16, 2018
    Assignee: Navitor Pharmaceuticals, Inc.
    Inventors: Kristina Michelle Fetalvero, Sridhar Narayan, David John O'Neill, Eddine Saiah, Shomit Sengupta
  • TETRAHYDROPYRAZOLOPYRIMIDINE COMPOUNDS
    Publication number: 20180273532
    Abstract: Embodiments of the disclosure relate to tetrahydropyrazolopyrimidine compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.
    Type: Application
    Filed: December 14, 2017
    Publication date: September 27, 2018
    Applicant: EISAI R&D MANAGEMENT CO., LTD.
    Inventors: Roch Boivin, Eric Carlson, Atsushi Endo, Hans Hansen, Lynn D. Hawkins, Sally Ishizaka, Matthew Mackey, Sridhar Narayan, Takashi Satoh, Shawn Schiller
  • Tetrahydropyrazolopyrimidine compounds
    Patent number: 9850242
    Abstract: Embodiments of the disclosure relate to tetrahydropyrazolopyrimidine compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.
    Type: Grant
    Filed: August 10, 2016
    Date of Patent: December 26, 2017
    Assignee: Eisai R&D Management Co., Ltd
    Inventors: Roch Boivin, Eric Carlson, Atsushi Endo, Hans Hansen, Lynn D. Hawkins, Sally Ishizaka, Matthew Mackey, Sridhar Narayan, Takashi Satoh, Shawn Schiller
  • Selectively substituted quinoline compounds
    Patent number: 9663486
    Abstract: Embodiments of the disclosure relate to selectively substituted quinoline compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.
    Type: Grant
    Filed: October 14, 2014
    Date of Patent: May 30, 2017
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Roch Boivin, Hans Hansen, Sally Ishizaka, Matthew Mackey, Shawn Schiller, Chikako Ogawa, Sridhar Narayan, Peter Bertinato, Gregory Berger, Atsushi Endo, Robert T. Yu, Lynn Hawkins
  • MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF
    Publication number: 20170114080
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: October 21, 2016
    Publication date: April 27, 2017
    Inventors: Kristina Michelle Fetalvero, Sridhar Narayan, David John O'Neill, Eddine Saiah, Shomit Sengupta
  • TETRAHYDROPYRAZOLOPYRIMIDINE COMPOUNDS
    Publication number: 20160339032
    Abstract: Embodiments of the disclosure relate to tetrahydropyrazolopyrimidine compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis
    Type: Application
    Filed: August 10, 2016
    Publication date: November 24, 2016
    Inventors: Roch Boivin, Eric Carlson, Atsushi Endo, Hans Hansen, Lynn D. Hawkins, Sally Ishizaka, Matthew Mackey, Sridhar Narayan, Takashi Satoh, Shawn Schiller
  • Tetrahydropyrazolopyrimidine compounds
    Patent number: 9446046
    Abstract: Embodiments of the disclosure relate to tetrahydropyrazolopyrimidine compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.
    Type: Grant
    Filed: July 22, 2015
    Date of Patent: September 20, 2016
    Assignee: EISAI R&D MANAGEMENT CO., LTD.
    Inventors: Roch Boivin, Eric Carlson, Atsushi Endo, Hans Hansen, Lynn D. Hawkins, Sally Ishizaka, Matthew Mackey, Sridhar Narayan, Takashi Satoh, Shawn Schiller